ETX.L - e-Therapeutics plc

LSE - LSE Delayed Price. Currency in GBp
0.00 (0.00%)
At close: 4:03PM GMT
Stock chart is not supported by your current browser
Previous Close6.75
Bid0.00 x 0
Ask0.00 x 0
Day's Range6.85 - 6.85
52 Week Range5.80 - 10.40
Avg. Volume497,406
Market Cap18.131M
Beta (3Y Monthly)-1.24
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Press Releases
  • ACCESSWIRE8 months ago

    Edison Issues Update On e-Therapeutics (ETX)

    LONDON, UK / ACCESSWIRE / April 23, 2018 / With the refocusing of the business and the new CEO's strategic review now implemented, e-Therapeutics (LSE: ETX) finds itself with the NDD platform and at least ...

  • Business Wire9 months ago

    e-therapeutics plc: Full Year Results

    e-therapeutics plc , the drug discovery company, announces its full year results for the year ended 31 January 2018.

  • ACCESSWIRE11 months ago

    Edison Issues Update on e-Therapeutics (ETX)

    LONDON, UK / ACCESSWIRE / January 5. 2018 / e-Therapeutics' (LSE: ETX) Network-Driven Drug Discovery (NDD) platform has begun to deliver encouraging data that should support out-licensing of its immuno-oncology ...